Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Essential Hypertension
IRCT201502011525N6Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of spironolactone in essential hypertension, sponsored by Shiraz University of Medical Sciences. Started Dec 2014; status: completed.
02
Drugs
spironolactone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on IRCT201502011525N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201502011525N6.